Gilead Sciences (GILD) Current Deferred Tax Assets (2016)
Historic Current Deferred Tax Assets for Gilead Sciences (GILD) over the last 8 years, with Q4 2016 value amounting to $857.0 million.
- Gilead Sciences' Current Deferred Tax Assets rose 350.24% to $857.0 million in Q4 2016 from the same period last year, while for Dec 2016 it was $857.0 million, marking a year-over-year increase of 350.24%. This contributed to the annual value of $857.0 million for FY2016, which is 350.24% up from last year.
- As of Q4 2016, Gilead Sciences' Current Deferred Tax Assets stood at $857.0 million, which was up 350.24% from $762.0 million recorded in Q3 2016.
- Over the past 5 years, Gilead Sciences' Current Deferred Tax Assets peaked at $894.0 million during Q3 2015, and registered a low of $193.9 million during Q1 2012.
- In the last 5 years, Gilead Sciences' Current Deferred Tax Assets had a median value of $385.6 million in 2014 and averaged $501.1 million.
- Its Current Deferred Tax Assets has fluctuated over the past 5 years, first tumbled by 3019.67% in 2012, then soared by 13245.66% in 2015.
- Over the past 5 years, Gilead Sciences' Current Deferred Tax Assets (Quarter) stood at $262.6 million in 2012, then grew by 26.03% to $331.0 million in 2013, then surged by 53.47% to $508.0 million in 2014, then soared by 62.99% to $828.0 million in 2015, then grew by 3.5% to $857.0 million in 2016.
- Its Current Deferred Tax Assets stands at $857.0 million for Q4 2016, versus $762.0 million for Q3 2016 and $835.0 million for Q2 2016.